Format

Send to

Choose Destination
Bone Marrow Transplant. 2019 Oct 1. doi: 10.1038/s41409-019-0705-z. [Epub ahead of print]

Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group.

Author information

1
Hematology Department, AP-HP, Hôpital Saint-Antoine, Sorbonne Université, Paris, France. mohamad.mohty@inserm.fr.
2
Hematology Department, AP-HP, Hôpital Saint-Antoine, Sorbonne Université, Paris, France.
3
Instituto Portugues de Oncologia, Lisbon, Portugal.
4
Department of Internal Medicine-Oncology, University Hospital Zurich, Zurich, Switzerland.
5
Department of Oncology, King Abdulaziz Medical City, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
6
King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
7
HSCT Unit, Sisli Florence Nightingale Hospital, Istanbul, Turkey.
8
Division for Stem Cell Transplantation and Immunology, Department for Children and Adolescents, University Hospital, Goethe University, Frankfurt/Main, Germany.
9
Department of Hematology, University of Liege, Liege, Belgium.
10
Medical University of Warsaw, Warsaw, Poland.
11
Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
12
Transplant and Cellular Immunotherapy Program, Department of Hematology, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille, France.
13
Hematology and Bone Marrow Transplantation Unit, IRCCS Ospedale San Raffaele, University Vita-Salute, Milano, Italy.
14
Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Regensburg, Regensburg, Germany.
15
Department of Hematology and Immunology, Hospital Robert Debre, Paris 7-Paris Diderot University, Paris, France.
16
Department of Clinical Haematology, Central Manchester Foundation Trust, Manchester, UK.
17
HSCT Division, National Cancer Center Hospital, Tokyo, Japan.
18
Hematology Department, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France.
19
Department of Haematology, University Medical Centre, Utrecht, The Netherlands.
20
Department of Hematology and Stem Cell Transplant Program, Hôpital Maisonneuve-Rosemont, University of Montreal, Montreal, QC, Canada.
21
Case Western Reserve University, Cleveland, OH, USA.
22
Department of Hematology and Stem Cell Transplantation, St. Istvan and St. Laszlo Hospital, Budapest 3 Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
23
Hematology Department, Groupement Hospitalier Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon EST, Pierre Bénite, France.
24
Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
25
National Stem Cell Transplant Unit (Adults), Department of Haematology, St James's Hospital and Academic Department of Haematology, Trinity College Dublin, Dublin, Ireland.
26
Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
27
Department of Haematological Medicine, King's College Hospital, London, UK.
28
Department of Pediatrics, St. Anna Kinderspital, 1090, Vienna, Austria.
29
LDS Hospital, Salt Lake City, UT, USA.
30
Division of Hematology, Mayo Clinic, Rochester, MN, USA.
31
Clinical Research Institute, Helsinki University Hospital, Helsinki, Finland.
32
Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA.
33
Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center and Veterans Affairs Medical Center, Nashville, TN, USA.
34
Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
35
Pediatric Hematology and Oncology, University Hospital, Collegium Medicum UMK, Bydgoszcz, Poland.
36
Section of Haematology and Coagulation, Department of Internal Medicine, Sahlgrenska University Hospital, Göteborg, Sweden.
37
CHU de Lille, LIRIC INSERM U995, Université de Lille2, Lille, France.
38
Department of Hematology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
39
Hematology Department, Josep Carreras Foundation and Leukemia Research Institute, Hospital Clínic, Barcelona, Spain.
PMID:
31576023
DOI:
10.1038/s41409-019-0705-z

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center